The first leukaemia patient to receive a breakthrough treatment since it was made available on the NHS has said it was ...
“You have this clear marker that you’re sick,” McQueen explains. “People feel entitled to speak about your illness in a way ...
The largest barriers to elimination are no longer scientific. The science and tech are finally here—women just need to catch ...
Applied Cells Inc. and Immuneel Therapeutics Private Limited today announced that the companies have entered into a collaboration framework to jointly evaluate application of Applied Cells' MARS(R) ...
Zacks Small Cap Research on MSN
YDES: YD Biopharma is an integrated biotechnology company that is poised to have a transformational year as it expands business operations
YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and ...
A new study led by researchers at UTHealth Houston investigated both gene expression and regulation at single cell levels to reveal disruptions in gene function in three brain regions of patients with ...
Your dermatologist or oncologist may have told you what type of advanced squamous cell carcinoma you have. Here’s what each type means: Locally advanced squamous cell carcinoma: This means cancer has ...
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...
Mitochondrial dysfunction is associated with various chronic diseases and cancers, including neurodegenerative diseases and ...
The largest single cell perturbation dataset to-date will be generated and released open source in a new team effort.
Supercharging immune cells could provide an effective way to tackle cancer, according to new research by scientists in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results